Trial Profile
Orencia remission Induction and Outcome Navigation Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ORION
- 07 Mar 2011 New trial record